John Fetterman's Latest Tweet About Iran Will Likely Anger Libs
You Cannot Dialogue With Evil
Here's More Info on the Terror Attack at an Austin Bar
Rep. Celeste Maloy's FREE Act Looks to Drastically Improve Federal Permit Bureaucracy
Another Victim of the Rhode Island Trans Shooter Has Died
President Trump Held Medal of Honor Ceremony and Updated the Nation on Iran....
SWAT Raid in Illinois Illustrates Stupidity of State's Gun Laws
Anti-Gun RINO May Be Finally Going Down to Plucky YouTuber
Isolationism Is an Embarrassment to American Strength
From Los Angeles to NYC: Iranian Americans Thank President Trump for Operation Epic...
Qatar Shoots Down Two Iranian Jets That Entered It's Airspace
The UN Responds to Iran Strikes With Its Favorite Weapon: A Strongly Worded...
Senator Adam Schiff Claims Iran Posed 'No Imminent Threat' to the United States
Six U.S. Service Members Killed: CENTCOM Provides Update Over First 48 Hours of...
U.S. Forces Destroy All Iranian Ships in the Gulf of Oman
Tipsheet

Meet the First Recipients of the Pfizer Vaccine

Meet the First Recipients of the Pfizer Vaccine
AP Photo/Richard Drewm Fuke

Margaret Keenan, a 90-year-old grandmother who turns 91 next week, became the first person to receive a dose of the Pfizer vaccine on Tuesday. She was given the shot at the UK's University Hospital Coventry at 6:31 a.m. She said she felt "so privileged to be the first person vaccinated against COVID-19."

Advertisement

"It's the best early birthday present I could wish for because it means I can finally look forward to spending time with my family and friends in the New Year after being on my own for most of the year," Keenan remarked.

Here in the U.S., the FDA is meeting on Thursday to discuss Pfizer's emergency authorization request. In clinical trials, the Pfizer vaccine candidate, which was developed in partnership with BioNTech, proved to be 95 percent effective and with "no serious safety concerns," a company statement read.

"The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform," the FDA's agenda for Thursday reads. "On December 10, 2020, the Center for Biologics Evaluation and Research’s (CBER), Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet in open session to discuss Emergency Use Authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 in individuals 16 years of age and older."

A second candidate, developed by Moderna, was over 94 percent effective. They too have requested an emergency authorization and the FDA will be meeting about that vaccine on Dec. 17.

Advertisement

"I think there's every chance that we will look back on...(Tuesday) as marking a decisive turning point in the battle against coronavirus," Simon Stevens, the CEO of England's National Health Service, said after the first dose was administered.

By the way, the second person to get a dose of the Pfizer vaccine in the UK is an 81-year-old man named William Shakespeare. Seriously.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement